晚期乳癌電子報分類文章　顯示方式：簡文 | 列表

2009年07月27日

晚期乳癌電子報 第 202 期

FDA新聞
FDA核准Tykerb用於晚期乳癌之治療
FDA Approves Tykerb for Advanced Breast Cancer Patients ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:44 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 198-201 期

HER-2陽性轉移乳癌：賀癌平治療的最佳化
HER-2 Positive Metastatic Breast Cancer: Optimizing Trastuzumab-Based Therapy
Oncologist 2006; 11; 34-41
...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:38 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 197 期

1.
併用 docetaxel+doxorubicin+長時間輸注5-FU治療局部晚期乳癌：第二期試驗
A Phase II Study of Docetaxel, Doxorubicin, and Infusional 5-Fluorouracil in the Treatment of Patients With Locally Advanced Breast Cancer.
American Journal of Clinical Oncology. 29(5):484-489, October 2006.

2.
併用健澤與 oxaliplatin 治療接受過 anthracycline 類藥物與紫杉醇類藥物治療的（或治療無效）的轉移乳癌病人：臨床與藥物動力學研究
Gemcitabine and Oxaliplatin in Patients With Metastatic Breast Cancer Resistant to or Pretreated With Both Anthracyclines and Taxanes: Clinical and Pharmacokinetic Data.
American Journal of Clinical Oncology. 29(5):490-494, October 2006. ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:36 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 196 期

1.
對於罹患 HER 2 陽性的轉移乳癌病人併用 vinorelbine 與 Herceptin 作為第一線治療：跨國第二期試驗
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial
British Journal of Cancer (2006) 95, 788-793.

2.
口服 paclitaxel (Paxoral)加上 ciclosporin對接受過anthracycline 類藥物治療之轉移乳癌病人的第二期與藥理學試驗
Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer
British Journal of Cancer (2006) 95, 794-800. ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:34 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 195 期

1.
西洋參萃取物之萃取方法影響人類乳癌細胞增生與雌激素受體之活化
Extraction-Dependent Effects of American Ginseng (Panax quinquefolium) on Human Breast Cancer Cell Proliferation and Estrogen Receptor Activation
Integrative Cancer Therapies, Vol. 5, No. 3, 236-243 (2006)

2.
使用傳統中藥之外科病人於手術期發生不良事件之發生率與危險
Incidence and Risk of Adverse Perioperative Events among Surgical Patients Taking Traditional Chinese Herbal Medicines.
Clinical Investigations
Anesthesiology. 105(3):454-461, September 2006. ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:33 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 194 期

老年女性乳癌病人手術後接受化學治療時間之延遲
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women
Breast Cancer Research and Treatment Volume 99, Number 3 / October, 2006 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:32 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 192 期

乳癌腦部轉移病人的預後因素
Prognostic factors affecting the outcome of brain metastases from breast cancer
Supportive Care in Cancer Volume 14, Number 9 / September, 2006
（這是國內幾家醫院合作的研究） ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:29 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 193 期

併用截瘤達與temozolomide治療乳癌腦部轉移病人的第一期試驗
Phase I Study Of Capecitabine In Combination With Temozolomide In The Treatment Of Patients With Brain Metastases From Breast Carcinoma
Cancer 2006; 107:1348-54 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:29 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 191 期

轉移乳癌病人長期接受 Herceptin 治療的心臟方面耐受性
Long-Term Cardiac Tolerability of Trastuzumab in Metastatic Breast Cancer: The M.D. Anderson Cancer Center Experience
Journal of Clinical Oncology, 10.1200/JCO.2005.04.9551 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:29 │ 回應(0) │ 引用(0)

晚期乳癌電子報 第 190 期

1.
Lapatinib 用於HER2陽性乳癌病人的腦部轉移之治療
Phase II trial of lapatinib for brain metastases in patients with HER2+ breast cancer.
Abstract No: 503
Citation: Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 503

2.

單僅使用lapatinib 治療復發／治療無效之發炎性乳癌
EGF103009, a phase II trial of lapatinib monotherapy in patients with relapsed/refractory inflammatory breast cancer (IBC): Clinical activity and biologic predictors of response.
Citation: Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 502 ...繼續閱讀

Posted by jaymyang at 樂多Roodo!│ 20:26 │ 回應(0) │ 引用(0)
 [第一頁]  [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  [下10頁]  [最終頁] 
回頁首▲